Pharsight Monthly Summary
July, 2026
Recent happenings in patent protected drugs.
spacer_11
At a Glance
107
drug patents lapsed
Photos
206
new drug patents introduced
Reviews
What's New on Pharsight?

Patent Challenge Updates

Discover for which innovator drugs Paragraph IV certifications have been filed, signaling opportunities to launch generics before patent expiry. Find this section right under Generic Launch on any drug page to stay ahead of the market and identify actionable opportunities.

Recent & Tentative Approvals

Track the latest innovator and generic drug approvals along with tentative approvals and submission timelines to identify drugs moving closer to market entry. This helps uncover pipeline momentum, anticipate upcoming launches, and better understand how a company’s portfolio is evolving. Simply search for any company on Pharsight and find this in the Recent Approvals & Tentative Approvals section of the company page.

spacer_11
spacer_11
spacer_11

High Competition Drugs Alert
See which drugs have the most crowded generic market and intense competition right now.
Drug (ANDA Filed) Primary Patent Status Market Size
Eliquis 25 Expiring Soon $13.3B
Latuda 14 Expired -
Bridion 14 Expired $1.8B
Tradjenta 11 Expired -
Opsumit 11 Expired $2.3B
Jentadueto 8 Expired -

Drug patents lapsed
Spot drugs with expired patents that present new generic development opportunities.
Drug Patent Patent expiry
Alyftrek 8354427 06 Jul, 2026
Alyftrek 8354427 06 Jul, 2026
Aplenzin 7241805 27 Jun, 2026
Aplenzin 7569610 27 Jun, 2026
Aplenzin 7572935 27 Jun, 2026
Aplenzin 7585897 27 Jun, 2026
Aplenzin 7645802 27 Jun, 2026
See more

Newly introduced Drug Patents
Discover the latest drugs receiving patent protection, signaling innovation and new market entrants
Drug Patent Patent expiry
Arakoda 12616689 02 Dec, 2035
Arikayce Kit 12616708 15 May, 2035
Atorvaliq 12599553 07 Jun, 2037
Auvelity 10058518 05 Nov, 2034
Auvelity 10080727 05 Nov, 2034
Auvelity 10092560 05 Nov, 2034
Auvelity 10105361 05 Nov, 2034
See more

Recent patent litigations
Stay updated on recent drug patent lawsuits shaping the competitive landscape.
Patent Petitioner Proceeding Date
US12280146 Sun Pharmaceutical Industries, Inc. 16 Jan, 2026
US12233106 Ascendis Pharma A/s 24 Nov, 2025
US11344552 Apotex Inc. 12 Sep, 2025
US9474780 Bpi Labs, Llc 04 Aug, 2025
US8268847 United Therapeutics Corporation 10 Jun, 2025
US9474780 Empower Clinic Services, Llc. (D/b/a Empower Pharmacy) 22 May, 2025
US8623826 Azurity Pharmaceuticals, Inc. 01 May, 2025
See in detail
spacer_11
Companies with Newly Granted Drug Substance Patents
Company Ingredient
Arvinas Operations Vepdegestrant
Astrazeneca Ab Baxdrostat
Beone Medicines Usa Sonrotoclax
Biocryst Berotralstat Dihydrochloride
Deciphera Pharms Vimseltinib
Incyte Corp Ruxolitinib Phosphate
Italfarmaco Spa Givinostat Hydrochloride
Msd Doravirine; Islatravir
Zevra Denmark Arimoclomol Citrate
spacer_11
View past newsletters
January, 2026
December, 2025
November, 2025

Our insights are consumed by 1000+ leading pharma companies

© 2026 GreyB Research